Pacific Biosciences of California Inc (PACB)

[Paulieme]

(I like this,older article) 6/11/2014--Roche doesn’t need to choose between the Genia instrument and PacBio’s, he says.

“It’s very possible the two platforms will complement each other,” Zabrowski says. PacBio is developing a new sequencer for Roche’s exclusive use in human genetic analysis, he says. “What we’ll see going forward is what are the best applications to be used with these technologies.”

PacBio remains free to sell its sequencing system already on the market, the PacBio RS II, which has developed a following among researchers seeking highly accurate sequences, or specializing in microbial genomes. PacBio’s equipment identifies the letters in a DNA sequence with light sensors, like traditional sequencers.
But both the Genia and PacBio systems can read the sequence of a single piece of DNA—a method that can increase the accuracy of results compared with most sequencers now on the market"---------- "Illumina, the market leader, said early this year that it had reached that $1,000 milestone. But Illumina’s low cost per genome can only be realized by organizations equipped with a $10 million bank of 10 Illumina sequencers working full tilt to scan thousands of genomes—thus benefitting from economies of scale." http://www.xconomy.com/san-francisco/2014/06/11/genia-sold-roche-to-incubate-another-novel-dna-sequencing-system/